A cross-linked polybenzimidazole proton exchange membrane, its preparation method and application
By pre-introducing phosphoric acid and epoxy crosslinking agents into the casting solution before film formation, a stable covalent crosslinking network is formed, solving the problems of uneven phosphoric acid distribution and decreased mechanical properties. This improves the proton conductivity and dimensional stability of high-temperature proton exchange membranes, making them suitable for the industrial production of high-temperature proton exchange membrane fuel cells.
Patent Information
- Application Number
- CN202611534335.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-30
- Publication Date
- 2026-11-17
AI Technical Summary
Existing polybenzimidazole proton exchange membranes suffer from uneven phosphoric acid distribution and decreased mechanical properties during preparation, and are difficult to produce continuously on an industrial scale.
Phosphoric acid and epoxy crosslinking agents are pre-introduced into the casting solution before film formation. Phosphorylated epoxy structure is formed through in-situ protonation. Combined with heat treatment, a stable covalent crosslinking network is constructed to achieve uniform distribution of phosphoric acid and proton conduction structure.
It improves the proton conductivity, dimensional stability, and mechanical properties of the proton exchange membrane, making it suitable for the industrial production of high-temperature proton exchange membrane fuel cells.
Smart Images

Figure CN123120799A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to a proton exchange membrane, specifically a cross-linked polybenzimidazole proton exchange membrane, and also to its preparation method and application, belonging to the field of proton exchange membrane fuel cell technology. Background Technology
[0002] High-temperature proton exchange membrane fuel cells (PEMFCs) have significant application prospects in distributed energy, stationary power sources, and transportation power due to their advanced electrode reaction kinetics, strong carbon monoxide tolerance, simplified hydrothermal management system, and high system efficiency. As one of the core materials of high-temperature PEMFCs, the proton exchange membrane's proton conductivity, mechanical strength, dimensional stability, and long-term operational stability directly affect the cell's performance.
[0003] Polybenzimidazole polymers possess excellent thermal stability, chemical stability, and mechanical properties, making them important matrix materials for high-temperature proton exchange membranes. The imidazole segments in polybenzimidazole contain imidazole structures, which can react with phosphoric acid to protonate the imidazole sites. This proton conduction channels are then formed through a network of hydrogen bonds between phosphoric acid molecules and between phosphoric acid and polybenzimidazole segments. Therefore, phosphoric acid doping or phosphoric acid protonation is crucial for achieving high-temperature proton conductivity in polybenzimidazole membranes.
[0004] Existing polybenzimidazole proton exchange membranes are typically prepared using a method of first forming the membrane and then immersing it in phosphoric acid. This involves first casting the polybenzimidazole solution into a membrane, then subjecting the resulting membrane to a second immersion in concentrated phosphoric acid, allowing the phosphoric acid to penetrate the membrane and protonate the imidazole sites. However, this post-processing has significant drawbacks: firstly, the diffusion of phosphoric acid from the membrane surface to the interior takes a considerable amount of time, easily leading to uneven phosphoric acid distribution within the membrane; secondly, immersion in high-concentration phosphoric acid can easily cause membrane swelling, dimensional changes, and a decline in mechanical properties. Furthermore, the second phosphoric acid immersion is an intermittent post-processing step, increasing the preparation cycle, washing, and transfer operations, and is not conducive to continuous coating, roll-to-roll membrane fabrication, or large-scale industrial production.
[0005] To improve the dimensional and mechanical stability of polybenzimidazole membranes, cross-linking modification methods are commonly used in existing technologies. However, simply immersing the membrane in phosphoric acid after deposition still suffers from problems such as long acid doping time, uneven acid distribution, and difficulties in continuous industrial production. Therefore, it is necessary to develop a polybenzimidazole proton exchange membrane with uniform phosphoric acid distribution, excellent electrochemical and mechanical properties, and high stability to avoid secondary phosphoric acid immersion after deposition and meet the requirements of roll-to-roll continuous production and industrial-scale preparation. Summary of the Invention
[0006] To address the deficiencies and shortcomings of existing technologies, this invention provides a method for preparing a crosslinked polybenzimidazole proton exchange membrane. The method involves dissolving a polybenzimidazole polymer in a polar aprotic solvent, adding an epoxy crosslinking agent and phosphoric acid, and mixing to obtain an in-situ pre-protonation casting solution of phosphoric acid. The in-situ pre-protonation casting solution of phosphoric acid is then used to form a film using a film-forming process, followed by heat treatment to obtain the final product.
[0007] This invention introduces phosphoric acid into the casting solution before film formation, enabling in-situ protonation of the phosphoric acid with the epoxy groups in the epoxy crosslinking agent, forming a highly reactive phosphorylated epoxy structure. On one hand, this pre-protonation process promotes uniform dispersion of the epoxy crosslinking agent and phosphoric acid in the casting solution and improves the interfacial compatibility between the crosslinking agent and the polybenzimidazole segments. On the other hand, the phosphorylated epoxy groups serve as protonation and proton transport sites, providing a synergistic effect for phosphoric acid distribution and proton conduction in the subsequent crosslinking network. During heat treatment, the activated phosphorylated epoxy groups further undergo ring-opening crosslinking reactions with the active sites in the polybenzimidazole segments, constructing a stable covalent crosslinking network within the film. Simultaneously, some phosphoric acid components are confined within the crosslinking structure, thereby inhibiting phosphoric acid migration and loss. Thus, the pre-protonation of phosphoric acid and the ring-opening crosslinking of epoxy work synergistically, improving crosslinking reaction efficiency and network uniformity while promoting the formation of continuous phosphoric acid enrichment and proton conduction structures within the film, achieving a synergistic improvement in proton conduction capacity, dimensional stability, and phosphoric acid retention capacity.
[0008] As a preferred embodiment, the amount of epoxy crosslinking agent added is 0.5~50 mol% of the polybenzimidazole polymer, more preferably 2~30 mol%. Controlling the amount of epoxy crosslinking agent added within a suitable range is beneficial to improving the overall performance of the proton exchange membrane.
[0009] As a preferred embodiment, the epoxy crosslinking agent includes at least one of the following: epoxy siloxane crosslinking agents, cage-type silsesquioxane epoxy crosslinking agents, aliphatic diglycidyl ether crosslinking agents, aromatic diglycidyl ether crosslinking agents, alicyclic diglycidyl ether crosslinking agents, and glycidyl ether crosslinking agents containing multiple functional groups.
[0010] Among them, epoxy siloxane crosslinking agents include compounds whose molecular structures simultaneously contain epoxy groups and siloxane structural units. The siloxane structural units possess high Si-O bond flexibility and thermal stability, enabling the formation of organic-inorganic hybrid crosslinking structures between PBI molecular chains. This improves the thermal stability, dimensional stability, and swelling resistance of the film while reducing the limitations imposed by excessive densification of the crosslinking network on polymer chain segment movement and proton transport.
[0011] Cage-type silsesquioxane epoxy crosslinking agents include compounds with a cage-type Si-O-Si framework structure and containing two or more epoxy groups. The cage-type silsesquioxane has a rigid spatial structure, which can form a three-dimensional crosslinking network with high spatial constraint between PBI molecular chains, thereby improving the mechanical strength, thermal stability, dimensional stability, and anti-swelling properties of the crosslinked film. Furthermore, by adjusting the amount of cage-type silsesquioxane added, the spatial structure and free volume distribution of the crosslinking network can be controlled.
[0012] Aliphatic diglycidyl ether crosslinking agents include compounds with aliphatic segments in their molecular structure and glycidyl ether groups at both ends. These aliphatic segments exhibit high flexibility, enabling the formation of relatively flexible molecular chain bridging structures. While achieving chemical crosslinking of PBI molecular chains, they maintain a certain degree of chain mobility, thereby improving the flexibility of the crosslinked film and reducing film embrittlement caused by excessively high crosslinking density.
[0013] Aromatic diglycidyl ether crosslinking agents include compounds with an aromatic ring structure and containing two glycidyl ether groups in their molecular structure. The aromatic ring structure has high rigidity, enabling the formation of a strong crosslinking network, thereby improving the mechanical strength, heat resistance, dimensional stability, and high-temperature creep resistance of PBI crosslinked films.
[0014] Alicyclic diglycidyl ether crosslinking agents include compounds with an alicyclic structure and containing two glycidyl ether groups in their molecular structure. The alicyclic structure can achieve a balance between rigidity and flexibility, giving the resulting crosslinked network both structural rigidity and segmental flexibility, thereby improving the mechanical strength, thermal stability, and dimensional stability of the film while maintaining good flexibility.
[0015] Glycidyl ether crosslinking agents containing multiple functional groups include compounds with two or more glycidyl ether groups, whose molecular structures can be aliphatic, alicyclic, aromatic, polyether, or a combination of the above structures. By adjusting the functionality, chain length, and addition ratio of the crosslinking agent, the crosslinking density, crosslinking network topology, and free volume between PBI molecular chains can be controlled, thereby achieving regulation of the swelling behavior, mechanical properties, phosphoric acid adsorption capacity, and proton transport performance of the crosslinked membrane.
[0016] As a preferred embodiment, the epoxy crosslinking agent comprises at least one of 1,3-bis(3-glycidoxypropyl)-1,1,3,3-tetramethyldisiloxane, 2,4,6,8-tetramethyl-2,4,6,8-tetra(3-(epoxyethylene-2-ylmethoxy)propyl)-1,3,5,7,2,4,6,8-tetraoxatetrasilcycloane, glycidoxypropyl cage-like polysilsesquioxane (GPOSS), ethylene glycol diglycidyl ether, 1,4-butanediol diglycidyl ether, resorcinol diglycidyl ether, 1,4-bis[(glycidoxy)methyl]cyclohexane, pentaerythritol glycidyl ether, and 1,6-hexanediol diglycidyl ether.
[0017] As a preferred embodiment, the amount of phosphoric acid added is 150-1000 wt% of the polybenzimidazole polymer, more preferably 300-800 wt%. By controlling the amount of phosphoric acid added, a suitable degree of pre-protonation is achieved between the pre-added phosphoric acid and the epoxy crosslinking agent, and it synergizes with the active sites of the polybenzimidazole chain segments and subsequent crosslinking reactions. When the amount of phosphoric acid added is too low, the degree of pre-protonation of the epoxy groups is insufficient, making it difficult to fully utilize the role of phosphoric acid in activating the crosslinking agent and constructing the proton conduction structure. The phosphoric acid content and continuous proton conduction channels in the membrane are insufficient, resulting in limited improvement in proton conductivity. When the amount of phosphoric acid added is too high, excessive phosphoric acid may weaken the inter-chain interactions of the polymer and increase the proportion of free phosphoric acid, which is not conducive to the effective confinement and fixation of phosphoric acid by the crosslinking network. Therefore, controlling the amount of phosphoric acid added within the above range can achieve a synergistic balance between phosphoric acid pre-protonation, epoxy ring-opening crosslinking, and phosphoric acid confinement, which is beneficial for constructing a uniform and stable crosslinked proton conduction network, while taking into account proton conductivity, dimensional stability, and phosphoric acid retention capacity.
[0018] As a preferred embodiment, the mass concentration of the phosphoric acid is 75-85%.
[0019] As a preferred embodiment, the polybenzimidazole polymer includes at least one of naphthalene-containing polybenzimidazole, meta-polybenzimidazole, para-polybenzimidazole, and poly[2,2'-(m-phenyl)-5,5'-bisbenzimidazole].
[0020] As a preferred embodiment, the concentration of the polybenzimidazole polymer in the in-situ preprotonation casting solution of phosphoric acid is 0.01~0.05 g / mL.
[0021] As a preferred embodiment, the polar aprotic solvent includes at least one of dimethyl sulfoxide, N,N-dimethylacetamide, N,N-dimethylformamide, and N-methylpyrrolidone.
[0022] As a preferred option, lithium chloride is added as a co-solvent when polybenzimidazole polymers cannot be completely dissolved in polar aprotic solvents.
[0023] As a preferred option, the casting process is as follows: the in-situ pre-protonated casting solution of phosphoric acid is cast onto the substrate surface, and then dried to remove the solvent.
[0024] As a preferred method, the drying process is as follows: drying at 60~80℃ for 12~24h under normal pressure, and then drying at 80~140℃ for 2~48h under vacuum.
[0025] As a preferred embodiment, the heat treatment conditions are: temperature of 100~200℃ and time of 0.5~24h.
[0026] The present invention also provides a cross-linked polybenzimidazole proton exchange membrane, which is prepared by the above method.
[0027] As a preferred embodiment, the thickness of the cross-linked polybenzimidazole proton exchange membrane is 20~80μm.
[0028] The present invention also provides an application of a cross-linked polybenzimidazole proton exchange membrane for the preparation of fuel cells.
[0029] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0030] (1) The cross-linked polybenzimidazole proton exchange membrane provided by the present invention has a continuous and uniform proton conduction structure, strong stability (size stability and thermal stability), and excellent mechanical properties and proton conduction properties, making it particularly suitable for use in high-temperature proton exchange membrane fuel cells, membrane electrode assemblies and related electrochemical energy conversion devices;
[0031] (2) The preparation method is simple and the cost is low, making it suitable for industrial-scale production. Attached Figure Description
[0032] Figure 1 The graphs show the polarization curves of the full cells in Examples 1-4 at 160-240°C.
[0033] Figure 2 The graphs show the polarization curves of the full cells in Examples 5-10 at 160-240°C.
[0034] Figure 3 The graph shows the polarization curve performance test results of the full cell corresponding to Comparative Example 1 at 160~240℃.
[0035] Figure 4 The graphs show the proton conductivity test results of Examples 1-10 and Comparative Example 1 at 100-240°C. Detailed Implementation
[0036] The present invention will be further described below with reference to the embodiments, but the scope of protection of the present invention is not limited to the following embodiments.
[0037] The naphthalene ring polybenzimidazole, polyarylene ether benzimidazole OPBI, and meta-aromatic polybenzimidazole mPBI used in this invention were all purchased from Changsha Lanmo Machinery Equipment Co., Ltd.
[0038] Example 1
[0039] (1) Weigh 0.50 g of naphthalene-cyclic polybenzimidazole, add it to 15 mL of dimethyl sulfoxide, and stir to dissolve at 80 °C to obtain a homogeneous polybenzimidazole solution.
[0040] (2) Add 1,3-bis(3-glycidoxypropyl)-1,1,3,3-tetramethyldisiloxane at 5 mol% relative to the obtained polybenzimidazole solution and continue stirring to obtain a polybenzimidazole casting solution containing a crosslinking agent.
[0041] (3) Add 2.00 g of phosphoric acid (mass concentration of 85%) to the polybenzimidazole casting solution containing the crosslinking agent, stir evenly, so that the phosphoric acid interacts with the imidazole sites in the polybenzimidazole chain segment and the crosslinking agent related sites to form in-situ preprotonation or phosphorylation interaction, and obtain the phosphoric acid in-situ preprotonated casting solution.
[0042] (4) After degassing the above-mentioned in-situ pre-protonation casting solution of phosphoric acid, it is cast onto a clean glass plate or other substrate surface, dried at a low temperature of 70°C for 15 hours, then dried under vacuum at 100°C for 15 hours, and then heat-treated at 150°C for 10 hours to allow the epoxy groups in the crosslinking agent to undergo a ring-opening crosslinking reaction with the active sites in the polybenzimidazole chain segments, thereby obtaining a crosslinked polybenzimidazole proton exchange membrane, denoted as nPBI-L5.
[0043] The polymer membranes prepared above were assembled into membrane electrode assemblies, and single-cell tests were conducted using LanMo Tech fuel cell testing equipment. Both the anode and cathode used a commercially available 40% Pt / C catalyst sprayed onto carbon paper as a catalyst layer, with a loading of 0.9 mg / cm³. 2 The effective area is 4 cm. 2 During testing, the hydrogen gas flow rate at the anode was 350 sccm, and the oxygen gas flow rate at the cathode was 400 sccm; no humidification was required. The fuel cell polarization curves from the open-circuit voltage to 0.2 V were recorded using a linear voltammetric scan method. The following examples and comparative examples all obtained fuel cell polarization curves according to this method.
[0044] Example 2
[0045] (1) Weigh 0.50 g of naphthalene-cyclic polybenzimidazole, add it to 10 mL of dimethyl sulfoxide, and stir to dissolve at 80 °C to obtain a homogeneous polybenzimidazole solution.
[0046] (2) Add 2,4,6,8-tetramethyl-2,4,6,8-tetra(3-(ethylene oxide-2-ylmethoxy)propyl)-1,3,5,7,2,4,6,8-tetraoxatetrasilcycloane to the obtained polybenzimidazole solution at 5 mol% relative to the naphthyl polybenzimidazole, and continue stirring and mixing to obtain a polybenzimidazole casting solution containing a crosslinking agent.
[0047] (3) Add 2.00 g of phosphoric acid (mass concentration of 85%) to the polybenzimidazole casting solution containing the crosslinking agent, stir evenly, so that the phosphoric acid interacts with the imidazole sites in the polybenzimidazole chain segment and the crosslinking agent related sites to form in-situ preprotonation or phosphorylation interaction, and obtain the phosphoric acid in-situ preprotonated casting solution.
[0048] (4) After degassing the above-mentioned in-situ pre-protonation casting solution of phosphoric acid, it is cast onto a clean glass plate or other substrate surface, dried at low temperature at 65°C for 18h, then dried under vacuum at 120°C for 12h, and then heat-treated at 170°C for 12h to allow the epoxy groups in the crosslinking agent to undergo a ring-opening crosslinking reaction with the active sites in the polybenzimidazole chain segment, thereby obtaining a crosslinked polybenzimidazole proton exchange membrane, denoted as nPBI-R5.
[0049] The crosslinking agent in this embodiment contains multiple epoxy functional groups, which can form a multi-point crosslinking structure with polybenzimidazole segments during heat treatment, thereby improving the dimensional stability and phosphoric acid retention capacity of the film.
[0050] Example 3
[0051] Crosslinked polybenzimidazole proton exchange membranes were prepared using the method described in Example 1, with the difference that the epoxy crosslinking agent was replaced with glycidyl etheroxypropyl cage-like polysilsesquioxane, and the molar addition was controlled at 15 mol%. The resulting membrane was denoted as nPBI-P15.
[0052] Example 4
[0053] Crosslinked polybenzimidazole proton exchange membranes were prepared using the method described in Example 1, with the difference being that the epoxy crosslinking agent was a complex of 1,3-bis(3-glycidoxypropyl)-1,1,3,3-tetramethyldisiloxane and 2,4,6,8-tetramethyl-2,4,6,8-tetra(3-(ethylene oxide-2-ylmethoxy)propyl)-1,3,5,7,2,4,6,8-tetraoxatetrasilcycloane, with a molar ratio of 1:1 and a total molar addition of 10 mol% of the naphthyl polybenzimidazole. The resulting membrane was designated nPBI-L5R5.
[0054] Example 5
[0055] Crosslinked polybenzimidazole proton exchange membranes were prepared using the method described in Example 1, with the difference that the molar amount of epoxy crosslinking agent added was controlled at 10 mol%, the solvent used was 10 mL NMP, and the resulting membrane was denoted as nPBI-L10.
[0056] Example 6
[0057] Crosslinked polybenzimidazole proton exchange membranes were prepared using the method described in Example 2, with the difference being that the molar amount of epoxy crosslinking agent added was controlled at 10 mol%, and the solvent used was a mixture of 10 mL NMP and DMSO with a volume ratio of NMP / DMSO of 1:4. The resulting membrane was designated as nPBI-R10.
[0058] Example 7
[0059] Crosslinked polybenzimidazole proton exchange membranes were prepared using the method described in Example 2, with the difference being that 0.50 g of polyarylene ether benzimidazole OPBI was weighed, the molar amount of epoxy crosslinking agent was controlled at 15 mol%, and the amount of phosphoric acid added was controlled at 4.00 g. The resulting membrane was designated as OPBI-R15-X.
[0060] Example 8
[0061] Crosslinked polybenzimidazole proton exchange membranes were prepared using the method described in Example 2, with the difference being that 0.50 g of meta-aromatic polybenzimidazole mPBI was weighed, the molar amount of epoxy crosslinking agent was controlled at 15 mol%, and the amount of phosphoric acid added was controlled at 4.00 g. The resulting membrane was designated as mPBI-L15-X.
[0062] Example 9
[0063] Crosslinked polybenzimidazole proton exchange membranes were prepared using the method described in Example 1, with the difference that the molar amount of epoxy crosslinking agent added was controlled at 15 mol%, and the amount of phosphoric acid added was controlled at 7.00 g. The resulting membrane was denoted as nPBI-L15-m.
[0064] Example 10
[0065] Crosslinked polybenzimidazole proton exchange membranes were prepared using the method described in Example 1, with the difference that the molar amount of epoxy crosslinking agent added was controlled at 15 mol%, and the amount of phosphoric acid added was controlled at 0.50 g. The resulting membrane was designated as nPBI-L15-l.
[0066] Comparative Example 1
[0067] The proton exchange membrane was prepared using the method of Example 1, except that no epoxy crosslinking agent was added, and the resulting membrane was denoted as nPBI.
[0068] from Figure 1 As can be seen, in Examples 1-4, different epoxy crosslinking agents can all produce proton exchange membranes with good performance. Within the test temperature range of 160-240 °C, the power density of each sample shows a trend of first increasing and then decreasing, reaching the highest peak power density at 220 °C. This indicates that the appropriate introduction of epoxy crosslinking agents can effectively improve the structural stability and proton transport performance of polybenzimidazole membranes, thereby improving the overall battery performance of the membrane electrode. At the same time, the test temperature affects the proton transport within the membrane and the battery reaction kinetics, exhibiting superior comprehensive performance near 220 °C.
[0069] from Figure 2 As can be seen, in Examples 5-8, appropriate adjustments to the solvent type, solvent ratio, and type of polybenzimidazole polymer all resulted in proton exchange membranes with excellent performance. Examples 9-10 show that excessively high or low phosphoric acid doping levels lead to a relative decrease in battery performance. This is because insufficient phosphoric acid doping results in a lack of effective proton transport sites within the membrane, while excessive doping affects the membrane's structural stability and gas transport characteristics. Therefore, the appropriate phosphoric acid doping level varies depending on the type and proportion of epoxy crosslinking agents used. It can be comprehensively controlled by considering factors such as the type of crosslinking agent, the addition ratio, and the polymer structure to obtain the optimal overall performance.
[0070] from Figure 3 As can be seen, the electrochemical performance of the proton exchange membrane prepared in Comparative Example 1 without the addition of epoxy crosslinking agent is significantly lower than that of the present invention. Compared with Example 1, its highest peak power density at 220°C is 76.5% higher than that of nPBI.
[0071] Figure 4 The proton conductivity test results of the above embodiments and comparative sample are provided by [the relevant authority / organization]. Figure 4 It can be seen that the cross-linked polybenzimidazole proton exchange membrane prepared in the embodiments of the present invention has excellent proton conductivity, while the proton conductivity of the proton exchange membrane in Comparative Example 1 is significantly lower than that in the embodiments of the present invention.
Claims
1. A method for preparing a cross-linked polybenzimidazole proton exchange membrane, characterized in that: Polybenzimidazole polymers are dissolved in a polar aprotic solvent, and epoxy crosslinking agents and phosphoric acid are added and mixed to obtain an in-situ pre-protonation casting solution of phosphoric acid. The in-situ pre-protonation casting solution of phosphoric acid is then used to form a film and then subjected to heat treatment to obtain the final product.
2. The method for preparing a cross-linked polybenzimidazole proton exchange membrane according to claim 1, characterized in that: The molar amount of the epoxy crosslinking agent is 0.5~50 mol% of the polybenzimidazole polymer. The epoxy crosslinking agent includes at least one of the following: epoxy siloxane crosslinking agent, cage-type silsesquioxane epoxy crosslinking agent, aliphatic diglycidyl ether crosslinking agent, aromatic diglycidyl ether crosslinking agent, alicyclic diglycidyl ether crosslinking agent, and glycidyl ether crosslinking agent containing multiple functional groups.
3. The method for preparing a cross-linked polybenzimidazole proton exchange membrane according to claim 2, characterized in that: The molar amount of the epoxy crosslinking agent is 2-30 mol% of the polybenzimidazole polymer. The epoxy crosslinking agent includes at least one of the following: 1,3-bis(3-glycidoxypropyl)-1,1,3,3-tetramethyldisiloxane, 2,4,6,8-tetramethyl-2,4,6,8-tetra(3-(epoxyethylene-2-ylmethoxy)propyl)-1,3,5,7,2,4,6,8-tetraoxatetrasilcycloane, glycidoxypropyl cage-like polysilsesquioxane, ethylene glycol diglycidyl ether, 1,4-butanediol diglycidyl ether, resorcinol diglycidyl ether, 1,4-bis[(glycidoxy)methyl]cyclohexane, pentaerythritol glycidyl ether, and 1,6-hexanediol diglycidyl ether.
4. The method for preparing a cross-linked polybenzimidazole proton exchange membrane according to claim 1 or 2, characterized in that: The amount of phosphoric acid added is 150~1000 wt% of the polybenzimidazole polymer; The mass concentration of the phosphoric acid is 75% to 85%.
5. The method for preparing a cross-linked polybenzimidazole proton exchange membrane according to claim 4, characterized in that: The amount of phosphoric acid added is 300-800 wt% of the polybenzimidazole polymer.
6. The method for preparing a cross-linked polybenzimidazole proton exchange membrane according to claim 1, characterized in that: The polybenzimidazole polymers include at least one of the following: naphthyl ring polybenzimidazole, meta-polybenzimidazole, para-polybenzimidazole, and poly[2,2'-(m-phenyl)-5,5'-bisbenzimidazole]. The concentration of the polybenzimidazole polymer in the in-situ preprotonation casting solution of phosphoric acid is 0.01~0.05 g / mL; The polar aprotic solvent includes at least one of dimethyl sulfoxide, N,N-dimethylacetamide, N,N-dimethylformamide, and N-methylpyrrolidone.
7. The method for preparing a cross-linked polybenzimidazole proton exchange membrane according to claim 1, characterized in that: The film-forming process is casting film formation; The heat treatment conditions are: temperature 100~200℃, time 0.5~24h.
8. A cross-linked polybenzimidazole proton exchange membrane, characterized in that: It is prepared by the method described in any one of claims 1 to 7.
9. The cross-linked polybenzimidazole proton exchange membrane according to claim 8, characterized in that: The thickness of the cross-linked polybenzimidazole proton exchange membrane is 20~80μm.
10. The application of the cross-linked polybenzimidazole proton exchange membrane according to claim 8 or 9, characterized in that: Used to manufacture fuel cells.
